terazosin

Product NDC: 23155-736
11-digit product format: 231550736
Labeler code: 23155
Product ID: 23155-736_daad3537-a1d2-451d-ab24-3d8649ff9487
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: terazosin
Dosage form: CAPSULE
Route: ORAL
Labeler: Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Application: ANDA075614
Marketing category: ANDA
Marketing start: 2021-04-30
Substance: TERAZOSIN HYDROCHLORIDE
Active strength: 2 mg/1
Pharmacologic classes: Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A075614-001	TERAZOSIN HYDROCHLORIDE	TERAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	2001-01-30
A075614-002	TERAZOSIN HYDROCHLORIDE	TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	2001-01-30
A075614-003	TERAZOSIN HYDROCHLORIDE	TERAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	2001-01-30
A075614-004	TERAZOSIN HYDROCHLORIDE	TERAZOSIN HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	2001-01-30

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
A075614-001	AB
A075614-002	AB
A075614-003	AB
A075614-004	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 164 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A075614-001	TERAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	2001-01-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075614-002	TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	2001-01-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075614-003	TERAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	2001-01-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075614-004	TERAZOSIN HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	2001-01-30	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075614-001	TERAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	2001-01-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075614-002	TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	2001-01-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075614-003	TERAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	2001-01-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075614-004	TERAZOSIN HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	2001-01-30	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A075614-001	TERAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	2001-01-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075614-002	TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	2001-01-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075614-003	TERAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	2001-01-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075614-004	TERAZOSIN HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	2001-01-30	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075614-001	TERAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	2001-01-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075614-002	TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	2001-01-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075614-003	TERAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	2001-01-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075614-004	TERAZOSIN HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	2001-01-30	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075614-001	TERAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	2001-01-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075614-002	TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	2001-01-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075614-003	TERAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	2001-01-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075614-004	TERAZOSIN HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	2001-01-30	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075614-001	TERAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	2001-01-30	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075614-002	TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	2001-01-30	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075614-003	TERAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	2001-01-30	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075614-004	TERAZOSIN HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	2001-01-30	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075614-001	TERAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	2001-01-30	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075614-002	TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	2001-01-30	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075614-003	TERAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	2001-01-30	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075614-004	TERAZOSIN HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	2001-01-30	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075614-001	TERAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	2001-01-30	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075614-002	TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	2001-01-30	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075614-003	TERAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	2001-01-30	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075614-004	TERAZOSIN HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	2001-01-30	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075614-001	TERAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	2001-01-30	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075614-002	TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	2001-01-30	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075614-003	TERAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	2001-01-30	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075614-004	TERAZOSIN HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	2001-01-30	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A075614-001	TERAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	2001-01-30	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075614-002	TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	2001-01-30	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075614-003	TERAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	2001-01-30	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075614-004	TERAZOSIN HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	AB	2001-01-30	`d06236e962d9…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 148 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A075614-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075614-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075614-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075614-004	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075614-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075614-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075614-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075614-004	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A075614-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075614-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075614-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075614-004	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075614-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075614-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075614-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075614-004	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075614-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075614-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075614-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075614-004	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075614-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075614-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075614-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075614-004	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075614-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075614-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075614-003	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075614-004	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075614-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075614-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075614-003	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075614-004	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075614-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075614-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075614-003	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075614-004	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A075614-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075614-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075614-003	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075614-004	AB	1	`d06236e962d9…`

Additional Listing Data#

Finished product: Yes
Brand name base: terazosin
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
TERAZOSIN HYDROCHLORIDE	2 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
D32S14F082	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
260376	Internal RxNorm lookup
313215	Internal RxNorm lookup
313217	Internal RxNorm lookup
313219	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1dabd4d6-3023-460a-8577-08b3690e7c93	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
975cd6e7-95ee-60f8-7c38-135ffbb09240	Product name	2	20260223
1bc6d1ac-ef0f-4fc6-8704-c443f03b274a	Product name	1	20250311
594e2c86-3079-4e6e-96c9-48f7a8afc78d	Product name	1	20230718
8adc9826-3fee-6091-f1ee-af9fd6f9caf8	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
23155-736-01	terazosin	100 in 1 BOTTLE	CAPSULE	100		2
23155-736-10	terazosin	1000 in 1 BOTTLE	CAPSULE	1000		2

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
23155-736-01	EA - Each	23155-736	4c4d13c2-3b64-4083-a4d3-7a73309e6cbb	1	2021-06-02
23155-736-10	EA - Each	23155-736	9fcbc491-103c-49eb-8c54-3a0d3012aadf	1	2021-06-02

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
23155-736	TERAZOSIN CAPSULE [HERITAGE PHARMACEUTICALS INC. D/B/A AVET PHARMACEUTICALS INC.]	2	Current NDC, Legacy NDC, 2 package rows	20211111_1dabd4d6-3023-460a-8577-08b3690e7c93.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
terazosin	TERAZOSIN	Aphena Pharma Solutions - Tennessee, LLC	57125b47-2156-181c-e063-6394a90ad763	2026-07-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075614 application number: ANDA075614
terazosin	TERAZOSIN	REMEDYREPACK INC.	77e01f71-f6d8-4bbe-b13e-352c7af6b1ef	2026-05-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075614 application number: ANDA075614
terazosin	TERAZOSIN	A-S Medication Solutions	916cf0fa-8e39-4b4d-b564-a16aa8511ff6	2026-01-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075614 application number: ANDA075614
terazosin	TERAZOSIN	Northwind Health Company, LLC	ff0efbc2-d7aa-9783-e053-6394a90a384f	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075614 application number: ANDA075614
Terazosin	TERAZOSIN	Chartwell RX, LLC	da4ca0f8-6888-447e-9948-d37196c5a19a	2025-12-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075614 application number: ANDA075614
terazosin	TERAZOSIN	Preferred Pharmaceuticals Inc.	a78f74ce-1c53-41ea-878e-13674db10a67	2025-09-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075614 application number: ANDA075614
terazosin	TERAZOSIN	Bryant Ranch Prepack	2cdbb03d-0ac9-477b-88f6-5d9492277048	2023-11-27	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075614 application number: ANDA075614
terazosin	TERAZOSIN	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	1dabd4d6-3023-460a-8577-08b3690e7c93	2021-08-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075614 application number: ANDA075614 ndc (product): 23155-736

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
D32S14F082	TERAZOSIN HYDROCHLORIDE	70024-40-7	TERAZOSIN HYDROCHLORIDE
8L5014XET7	TERAZOSIN	63590-64-7	terazosin

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
313217	terazosin HCl 2 MG Oral Capsule	PSN	a78f74ce-1c53-41ea-878e-13674db10a67	4
313217	terazosin 2 MG Oral Capsule	SCD	a78f74ce-1c53-41ea-878e-13674db10a67	4
313217	terazosin (as terazosin HCl) 2 MG Oral Capsule	SY	a78f74ce-1c53-41ea-878e-13674db10a67	4
313215	terazosin HCl 1 MG Oral Capsule	PSN	1dabd4d6-3023-460a-8577-08b3690e7c93	2
260376	terazosin HCl 10 MG Oral Capsule	PSN	1dabd4d6-3023-460a-8577-08b3690e7c93	2
313217	terazosin HCl 2 MG Oral Capsule	PSN	1dabd4d6-3023-460a-8577-08b3690e7c93	2
313217	terazosin HCl 2 MG Oral Capsule	PSN	ff0efbc2-d7aa-9783-e053-6394a90a384f	2
313219	terazosin HCl 5 MG Oral Capsule	PSN	1dabd4d6-3023-460a-8577-08b3690e7c93	2
313215	terazosin 1 MG Oral Capsule	SCD	1dabd4d6-3023-460a-8577-08b3690e7c93	2
260376	terazosin 10 MG Oral Capsule	SCD	1dabd4d6-3023-460a-8577-08b3690e7c93	2
313217	terazosin 2 MG Oral Capsule	SCD	ff0efbc2-d7aa-9783-e053-6394a90a384f	2
313217	terazosin 2 MG Oral Capsule	SCD	1dabd4d6-3023-460a-8577-08b3690e7c93	2
313219	terazosin 5 MG Oral Capsule	SCD	1dabd4d6-3023-460a-8577-08b3690e7c93	2
313215	terazosin (as terazosin HCl) 1 MG Oral Capsule	SY	1dabd4d6-3023-460a-8577-08b3690e7c93	2
260376	terazosin (as terazosin HCl) 10 MG Oral Capsule	SY	1dabd4d6-3023-460a-8577-08b3690e7c93	2
313217	terazosin (as terazosin HCl) 2 MG Oral Capsule	SY	1dabd4d6-3023-460a-8577-08b3690e7c93	2
313217	terazosin (as terazosin HCl) 2 MG Oral Capsule	SY	ff0efbc2-d7aa-9783-e053-6394a90a384f	2
313219	terazosin (as terazosin hydrochloride) 5 MG Oral Capsule	SY	1dabd4d6-3023-460a-8577-08b3690e7c93	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
23155-736-01	23155073601	100 CAPSULE in 1 BOTTLE (23155-736-01)	100 capsule	2021-04-30	0000-00-00	No	No	Current
23155-736-10	23155073610	1000 CAPSULE in 1 BOTTLE (23155-736-10)	1000 capsule	2021-04-30	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Terazosin Capsules, USP	Northwind Health Company, LLC	2026-01-01	HUMAN PRESCRIPTION DRUG LABEL	2
Terazosin Capsules, USP	Preferred Pharmaceuticals Inc.	2025-09-30	HUMAN PRESCRIPTION DRUG LABEL	4
Terazosin Capsules, USP	REMEDYREPACK INC.	2025-07-17	HUMAN PRESCRIPTION DRUG LABEL	5
Terazosin Capsules, USP	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. \| Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc.	2021-08-18	HUMAN PRESCRIPTION DRUG LABEL	2